CENTELION
USPTO Trademark Record · Serial No. 79009687
Trademark details
It was initially claimed by AVENTIS PHARMA S.A. on 20041126.
That brand applies to the following goods and services:pharmaceuticals used in gene and cell therapy for treating oncologic, cardiovascular, immunological, respiratory, central nervous system or psychologic disorders, pharmaceutical, medical and scientific research and development services for new products, medical care in connection with gene and cell therapies.
Currently that trademark is represented by trademark attorney(s): Susan Upton Douglass.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the CENTELION trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
